This project aimed to demonstrate that the use of a structured questionnaire can assist pharmacists to identify patients for whom over-the-counter vaginal antifungal therapy is appropriate based on their symptoms. It also evaluated the cost benefits of allowing pharmacists to sell such products.
This project was funded by the Department of Health and Ageing via the Third Community Pharmacy Agreement.
The full report can be viewed at the Pharmacy Guild of Australia website.
For more information, please contact UMORE.